Roche received emergency-use authorization from the U.S. Food and Drug Administration for its new Covid-19 antibody test, the company said.

Roche Holding AG received emergency-use authorization from the U.S. Food and Drug Administration for its new Covid-19 antibody test, the company said in a statement.

The Elecsys Anti-SARS-CoV-2 test is designed to determine if a patient has been exposed to the coronavirus and has developed antibodies against it, according to the statement.